1. Home
  2. RUSHA vs RARE Comparison

RUSHA vs RARE Comparison

Compare RUSHA & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rush Enterprises Inc. Cl A

RUSHA

Rush Enterprises Inc. Cl A

HOLD

Current Price

$66.06

Market Cap

4.9B

ML Signal

HOLD

Logo Ultragenyx Pharmaceutical Inc.

RARE

Ultragenyx Pharmaceutical Inc.

HOLD

Current Price

$20.16

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RUSHA
RARE
Founded
1965
2010
Country
United States
United States
Employees
7355
N/A
Industry
Retail-Auto Dealers and Gas Stations
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
2.1B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
RUSHA
RARE
Price
$66.06
$20.16
Analyst Decision
Buy
Strong Buy
Analyst Count
3
18
Target Price
$71.33
$61.22
AVG Volume (30 Days)
424.0K
1.6M
Earning Date
04-29-2026
05-05-2026
Dividend Yield
1.21%
N/A
EPS Growth
N/A
7.31
EPS
N/A
N/A
Revenue
N/A
$673,000,000.00
Revenue This Year
N/A
$13.40
Revenue Next Year
$3.98
$42.83
P/E Ratio
$21.36
N/A
Revenue Growth
N/A
20.13
52 Week Low
$45.67
$18.41
52 Week High
$75.99
$40.17

Technical Indicators

Market Signals
Indicator
RUSHA
RARE
Relative Strength Index (RSI) 51.92 35.26
Support Level $61.12 $19.61
Resistance Level $75.99 $23.44
Average True Range (ATR) 2.11 0.75
MACD -0.30 -0.13
Stochastic Oscillator 48.09 4.72

Price Performance

Historical Comparison
RUSHA
RARE

About RUSHA Rush Enterprises Inc. Cl A

Rush Enterprises Inc is a full-service, integrated retailer of commercial vehicles and related services. The company operates in a single segment; Truck Segment includes the operation of a network of commercial vehicle dealerships under the name Rush Truck Centers. It sells commercial vehicles manufactured by Peterbilt, International, Hino, Ford, Isuzu, IC Bus, and Blue Bird and also provides one-stop service for the needs of commercial vehicle customers, including retail sales of new and used commercial vehicles, aftermarket parts sales, service and repair facilities, financing, leasing and rental, and insurance products. The company's business is concentrated in the United States and Ontario, Canada commercial vehicle markets and related aftermarkets.

About RARE Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. The company identifies, acquires, develops, and commercializes novel products for the treatment of serious, rare, and ultra-rare diseases, with a focus on debilitating genetic conditions. Its medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients aged one year and older. Mepsevii is indicated for pediatric and adult patients for the treatment of Mucopolysaccharidosis VII. The company operates across North America, Latin America, Europe, the Middle East and Africa, and Asia-Pacific, with the majority of its revenue generated from North America.

Share on Social Networks: